0001404644-24-000067.txt : 20240617
0001404644-24-000067.hdr.sgml : 20240617
20240617143537
ACCESSION NUMBER: 0001404644-24-000067
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240614
FILED AS OF DATE: 20240617
DATE AS OF CHANGE: 20240617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freedland Cory S.
CENTRAL INDEX KEY: 0001832569
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36327
FILM NUMBER: 241047790
MAIL ADDRESS:
STREET 1: 628 MIDDLEFIELD ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neurogene Inc.
CENTRAL INDEX KEY: 0001404644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 980542593
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 W 24TH STREET
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: (877) 237-5020
MAIL ADDRESS:
STREET 1: 535 W 24TH STREET
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10011
FORMER COMPANY:
FORMER CONFORMED NAME: Neoleukin Therapeutics, Inc.
DATE OF NAME CHANGE: 20190812
FORMER COMPANY:
FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC
DATE OF NAME CHANGE: 20140128
FORMER COMPANY:
FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC
DATE OF NAME CHANGE: 20070626
4
1
wk-form4_1718649330.xml
FORM 4
X0508
4
2024-06-14
0
0001404644
Neurogene Inc.
NGNE
0001832569
Freedland Cory S.
C/O NEUROGENE INC.
535 W 24TH STREET, 5TH FLOOR
NEW YORK
NY
10011
1
0
0
0
0
Stock Option (Right to Buy)
42.59
2024-06-14
4
A
0
7700
0
A
2034-06-14
Common Stock
7700
7700
D
This option represents a right to purchase 7,700 shares of the Issuer's common stock, which will vest in its entirety on the earlier of (a) the first anniversary of the date of grant or (b) the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such applicable vesting date.
/s/ Christine Mikail, as attorney-in-fact for Cory S. Freedland
2024-06-17